Shopping Cart

Expired activity

Please go to the PowerPak homepage and select a course.

Overview

Our expert faculty, comprised of a managed care pharmacist and pulmonologist specializing in PAH, review recent guideline recommendations and strategies for selecting appropriate therapy, including initial combination regimens, as well as financial considerations based on managed care pharmacy protocols.

Published:

December 12, 2019

Expires:

December 12, 2020

FACULTY

H. Eric Cannon, PharmD, FAMCP
VP, Pharmacy Benefits, SelectHealth
Murray, UT

Dan Schuller, MD
Chair and Professor, Department of Internal Medicine - The Hospitals of Providence - Transmountain
Texas Tech University Health Sciences Center - Paul L. Foster School of Medicine
El Paso, Texas

Disclaimer

The content for this activity was developed independently of the commercial supporters. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support, as well as the ACPE Accreditation Standards for Continuing Pharmacy Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE/CPE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE/CPE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE/CPE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers' prescribing information for these products. Purdue University College of Pharmacy requires the speaker to disclose that a product is not labeled for the use under discussion.

TARGET AUDIENCE

This activity is intended for pharmacists, physicians, and other clinicians involved in the treatment of patients with PAH.

Activity Purpose

Therapeutic selection and management in PAH are intertwined with differential diagnostics, disease classification, and risk stratification. If the wrong disease classification/risk stratification is made at the incorrect time, inappropriate therapy is often offered, resulting in poor clinical outcomes. Managed care pharmacists must be prepared to update formularies and related dispensing/management protocols to improve outcomes and manage the high costs associated with unnecessary hospitalizations.

Learning Objectives

Upon completion of this program, participants should be better able to:

• Discuss the role of evidence-based PAH diagnostics and disease classification in therapeutic selection and related formulary decision making.
• List specialty pharmacy best practices and related formulary protocols for improving suboptimal PAH therapeutics and outcomes.
• Describe administrative and/or medical-coding barriers which may impede timely patient access to appropriate PAH therapies.
• Discuss the role of initial PAH combination therapy in reducing overall healthcare utilization costs in PAH patients.
• Evaluate novel and emerging PAH therapies/devices and their role in related PAH utilization management.

Method of Participation

This activity will take approximately 60 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Laurie Novoryta at [email protected].

To receive Credit, you must provide your date of birth and NABP number. CPE credit will be uploaded into CPE monitor within 30 days.

Continuing Pharmacy Education Statement

Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge-based continuing education activity of Purdue University, an equal access/equal opportunity institution.
Universal Activity Number: 0018-9999-19-048-H01-P, 1.00 contact hours (.10 CEU).

Faculty Disclosures

Purdue University College of Pharmacy requires that the faculty participating in a CE/CPE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CE/CPE activity.

The following financial relationships have been provided:
H. Eric Cannon, PharmD, FAMCP (Faculty)
No relevant financial relationships

Dan Schuller, MD (Faculty)
Speakers Bureau: Bayer HealthCare Pharmaceuticals, Gilead

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Hardware and Software Requirements

All additional planning committee members, ACHL, and Purdue University College of Pharmacy staff have no relationships to disclose.

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
4. Adobe Flash Player 12.0 (or higher). Click here to download Adobe Flash Player for free.
5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.
6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker